# Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

> **NCT00090376** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 240 (—)

## Conditions studied

- Impotence
- Prostate Cancer

## Interventions

- **DRUG:** GPI 1485

## Key facts

- **NCT ID:** NCT00090376
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 240 (—)
- **Last updated:** 2008-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090376, "Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*